New study: Daily cholesterol pill lowers LDL levels by up to 60 percent

Date:

Share this article:

Del denne artikel:

There’s something strangely familiar about those routine health checkups where you promise yourself you’ll “take cholesterol more seriously this time.”

Most of us know the feeling of seeing numbers creep upward, even when we’re doing our best to eat better or move more.

And for many, the idea of adding yet another injection or complicated treatment can feel overwhelming — especially if high cholesterol runs in the family.

A simpler approach for people who struggle to reach healthy levels

Across the world, researchers have been working on treatments that fit more naturally into everyday routines.

Also read: Study suggests humans can detect objects before touching them

One of the most promising developments comes from a large international study of an experimental pill called Enlicitide — a tablet designed for people whose cholesterol stays high despite existing medication.

The research included adults diagnosed with heterozygous familial hypercholesterolemia, a genetic condition that pushes LDL (“bad”) cholesterol to dangerous levels from an early age.

Participants were already on lipid-lowering therapies, but many still couldn’t reach safe targets.

The numbers that caught researchers’ attention

The group receiving Enlicitide once daily saw steep reductions in harmful fats over the course of the year. According to the study published in JAMA, the pill led to:

  • About 58 percent lower LDL after 24 weeks, stabilizing near 55 percent after a year
  • A 52 percent reduction in non-HDL cholesterol
  • A 48 percent drop in apolipoprotein B
  • Nearly 25 percent lower lipoprotein(a)

These are levels typically achieved only with injectable PCSK9 blockers — making a daily pill an attractive alternative for many patients.

Also read: New data shows Long COVID rarely follows a single pattern

What scientists still need to understand

The trial did not yet examine whether the pill reduces heart attacks, strokes or long-term mortality, and researchers emphasize that larger outcome studies are underway.

The medication was tested only in people with a specific genetic condition, so its effect in those with common high cholesterol is still unknown.

For now, the findings point to a future where managing inherited cholesterol disorders may be easier — and far more accessible — than before.

The article is based on information from Fox News Digital og JAMA

Also read: New study: Plant-based diet is most effective for weight loss

Also read: Christmas songs that could make falling asleep easier

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Taking any of these common drugs? Mixing them with alcohol may be dangerous

A federal health agency keeps a surprisingly long list of medicines that turn risky the moment a drink enters the picture.

He drank 13 cups of water every day for a week: Here’s what happened

What happens when you start drinking more water in your daily life?One man decided to drink 13 cups...

How much fiber should you eat per day? The target sorted by age and sex

The average plate falls short by half, and most people have never been told what their personal number should be.

Cervical cancer deaths could rise nearly 40 percent by 2050

A new study carries a sobering message about one cancer where effective tools have been available for years.

Taking any of these common drugs? Mixing them with alcohol may be dangerous

A federal health agency keeps a surprisingly long list of medicines that turn risky the moment a drink enters the picture.

He drank 13 cups of water every day for a week: Here’s what happened

What happens when you start drinking more water in your daily life?One man decided to drink 13 cups...

How much fiber should you eat per day? The target sorted by age and sex

The average plate falls short by half, and most people have never been told what their personal number should be.